253 related articles for article (PubMed ID: 34545084)
1. Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma.
DeSisto J; Lucas JT; Xu K; Donson A; Lin T; Sanford B; Wu G; Tran QT; Hedges D; Hsu CY; Armstrong GT; Arnold M; Bhatia S; Flannery P; Lemma R; Hardie L; Schüller U; Venkataraman S; Hoffman LM; Dorris K; Mulcahy Levy JM; Hankinson TC; Handler M; Liu AK; Foreman N; Vibhakar R; Jones K; Allen S; Zhang J; Baker SJ; Merchant TE; Orr BA; Green AL
Nat Commun; 2021 Sep; 12(1):5531. PubMed ID: 34545084
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B.
Deng MY; Sturm D; Pfaff E; Sill M; Stichel D; Balasubramanian GP; Tippelt S; Kramm C; Donson AM; Green AL; Jones C; Schittenhelm J; Ebinger M; Schuhmann MU; Jones BC; van Tilburg CM; Wittmann A; Golanov A; Ryzhova M; Ecker J; Milde T; Witt O; Sahm F; Reuss D; Sumerauer D; Zamecnik J; Korshunov A; von Deimling A; Pfister SM; Jones DTW
Nat Commun; 2021 Sep; 12(1):5530. PubMed ID: 34545083
[TBL] [Abstract][Full Text] [Related]
3. Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis.
Whitehouse JP; Howlett M; Federico A; Kool M; Endersby R; Gottardo NG
Neurooncol Adv; 2021; 3(1):vdab109. PubMed ID: 34859225
[TBL] [Abstract][Full Text] [Related]
4. The genetic landscape of gliomas arising after therapeutic radiation.
López GY; Van Ziffle J; Onodera C; Grenert JP; Yeh I; Bastian BC; Clarke J; Oberheim Bush NA; Taylor J; Chang S; Butowski N; Banerjee A; Mueller S; Kline C; Torkildson J; Samuel D; Siongco A; Raffel C; Gupta N; Kunwar S; Mummaneni P; Aghi M; Theodosopoulos P; Berger M; Phillips JJ; Pekmezci M; Tihan T; Bollen AW; Perry A; Solomon DA
Acta Neuropathol; 2019 Jan; 137(1):139-150. PubMed ID: 30196423
[TBL] [Abstract][Full Text] [Related]
5. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
[TBL] [Abstract][Full Text] [Related]
6. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.
Wiestler B; Capper D; Sill M; Jones DT; Hovestadt V; Sturm D; Koelsche C; Bertoni A; Schweizer L; Korshunov A; Weiß EK; Schliesser MG; Radbruch A; Herold-Mende C; Roth P; Unterberg A; Hartmann C; Pietsch T; Reifenberger G; Lichter P; Radlwimmer B; Platten M; Pfister SM; von Deimling A; Weller M; Wick W
Acta Neuropathol; 2014 Oct; 128(4):561-71. PubMed ID: 25008768
[TBL] [Abstract][Full Text] [Related]
7. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
[TBL] [Abstract][Full Text] [Related]
8. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
[TBL] [Abstract][Full Text] [Related]
9. Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.
Koschmann C; Zamler D; MacKay A; Robinson D; Wu YM; Doherty R; Marini B; Tran D; Garton H; Muraszko K; Robertson P; Leonard M; Zhao L; Bixby D; Peterson L; Camelo-Piragua S; Jones C; Mody R; Lowenstein PR; Castro MG
Oncotarget; 2016 Oct; 7(40):65696-65706. PubMed ID: 27582545
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Aoki K; Nakamura H; Suzuki H; Matsuo K; Kataoka K; Shimamura T; Motomura K; Ohka F; Shiina S; Yamamoto T; Nagata Y; Yoshizato T; Mizoguchi M; Abe T; Momii Y; Muragaki Y; Watanabe R; Ito I; Sanada M; Yajima H; Morita N; Takeuchi I; Miyano S; Wakabayashi T; Ogawa S; Natsume A
Neuro Oncol; 2018 Jan; 20(1):66-77. PubMed ID: 29016839
[TBL] [Abstract][Full Text] [Related]
11. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.
Paugh BS; Qu C; Jones C; Liu Z; Adamowicz-Brice M; Zhang J; Bax DA; Coyle B; Barrow J; Hargrave D; Lowe J; Gajjar A; Zhao W; Broniscer A; Ellison DW; Grundy RG; Baker SJ
J Clin Oncol; 2010 Jun; 28(18):3061-8. PubMed ID: 20479398
[TBL] [Abstract][Full Text] [Related]
12. Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.
Broniscer A; Hwang SN; Chamdine O; Lin T; Pounds S; Onar-Thomas A; Chi L; Shurtleff S; Allen S; Gajjar A; Northcott P; Orr BA
Brain Pathol; 2018 Jan; 28(1):112-120. PubMed ID: 28032389
[TBL] [Abstract][Full Text] [Related]
13. IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations.
Yang RR; Shi ZF; Zhang ZY; Chan AK; Aibaidula A; Wang WW; Kwan JSH; Poon WS; Chen H; Li WC; Chung NY; Punchhi G; Chu WC; Chan IS; Liu XZ; Mao Y; Li KK; Ng HK
Brain Pathol; 2020 May; 30(3):541-553. PubMed ID: 31733156
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.
Ramalho-Carvalho J; Pires M; Lisboa S; Graça I; Rocha P; Barros-Silva JD; Savva-Bordalo J; Maurício J; Resende M; Teixeira MR; Honavar M; Henrique R; Jerónimo C
PLoS One; 2013; 8(3):e58206. PubMed ID: 23505468
[TBL] [Abstract][Full Text] [Related]
15. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
16. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
[TBL] [Abstract][Full Text] [Related]
18. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
19. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
Petralia F; Tignor N; Reva B; Koptyra M; Chowdhury S; Rykunov D; Krek A; Ma W; Zhu Y; Ji J; Calinawan A; Whiteaker JR; Colaprico A; Stathias V; Omelchenko T; Song X; Raman P; Guo Y; Brown MA; Ivey RG; Szpyt J; Guha Thakurta S; Gritsenko MA; Weitz KK; Lopez G; Kalayci S; Gümüş ZH; Yoo S; da Veiga Leprevost F; Chang HY; Krug K; Katsnelson L; Wang Y; Kennedy JJ; Voytovich UJ; Zhao L; Gaonkar KS; Ennis BM; Zhang B; Baubet V; Tauhid L; Lilly JV; Mason JL; Farrow B; Young N; Leary S; Moon J; Petyuk VA; Nazarian J; Adappa ND; Palmer JN; Lober RM; Rivero-Hinojosa S; Wang LB; Wang JM; Broberg M; Chu RK; Moore RJ; Monroe ME; Zhao R; Smith RD; Zhu J; Robles AI; Mesri M; Boja E; Hiltke T; Rodriguez H; Zhang B; Schadt EE; Mani DR; Ding L; Iavarone A; Wiznerowicz M; Schürer S; Chen XS; Heath AP; Rokita JL; Nesvizhskii AI; Fenyö D; Rodland KD; Liu T; Gygi SP; Paulovich AG; Resnick AC; Storm PB; Rood BR; Wang P; ;
Cell; 2020 Dec; 183(7):1962-1985.e31. PubMed ID: 33242424
[TBL] [Abstract][Full Text] [Related]
20. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.
Vaubel RA; Caron AA; Yamada S; Decker PA; Eckel Passow JE; Rodriguez FJ; Nageswara Rao AA; Lachance D; Parney I; Jenkins R; Giannini C
Brain Pathol; 2018 Mar; 28(2):172-182. PubMed ID: 28181325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
